Related Experiment Video

Updated: Apr 24, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

8.4K

RASAL2 down-regulation in ovarian cancer promotes epithelial-mesenchymal transition and metastasis

Yuting Huang1, Meng Zhao2, Haixu Xu3

  • 1Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, P.R. China. Department of Immunology, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Educational Ministry of China, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, P.R. China. These authors contributed equally to this work.

Oncotarget
|September 13, 2014
PubMed

Insights

RASAL2 acts as a tumor suppressor in ovarian cancer by inhibiting epithelial-mesenchymal transition (EMT) and metastasis. Its down-regulation promotes cancer progression through the Ras-ERK pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gynecologic Cancers

Background:

  • Ovarian cancer is a highly lethal gynecologic malignancy, with transcoelomic metastasis being a major cause of mortality.
  • The mechanisms driving ovarian cancer metastasis remain incompletely understood.
  • RASAL2, a GTPase activating protein (GAP), has been identified as a tumor suppressor in breast cancer.

Purpose of the Study:

  • To investigate the role of RASAL2 in regulating epithelial-mesenchymal transition (EMT) and metastasis in ovarian cancer.
  • To determine the expression levels of RASAL2 in ovarian cancer tissues and correlate them with disease stage and grade.
  • To elucidate the molecular mechanisms by which RASAL2 influences ovarian cancer progression.

Main Methods:

  • Analysis of RASAL2 expression in ovarian cancer samples compared to normal tissues.
  • RASAL2 knockdown in ovarian cancer cell lines to assess effects on in vitro growth, migration, invasion, and in vivo tumor formation.
  • Examination of EMT markers, cell-cell adhesion molecules (E-cadherin), and mesenchymal markers.
  • Investigation of the Ras-ERK signaling pathway activation and the effect of pathway inhibition.

Main Results:

  • RASAL2 was significantly down-regulated in ovarian cancer tissues, particularly in advanced stages and grades.
  • RASAL2 depletion promoted anchorage-independent growth, migration, invasion, and tumor formation in ovarian cancer models.
  • RASAL2 knockdown induced EMT, characterized by decreased E-cadherin and increased mesenchymal markers.
  • The oncogenic effects of RASAL2 down-regulation were mediated by activation of the Ras-ERK pathway.

Conclusions:

  • RASAL2 functions as a regulator of EMT and a tumor suppressor in ovarian cancer.
  • Down-regulation of RASAL2 promotes ovarian cancer progression and metastasis.
  • Targeting the Ras-ERK pathway may offer therapeutic strategies for ovarian cancer with low RASAL2 expression.

More Related Videos

A Proximal Culture Method to Study Paracrine Signaling Between Cells08:17

A Proximal Culture Method to Study Paracrine Signaling Between Cells

Published on: August 28, 2018

9.4K
Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity09:00

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity

Published on: December 31, 2015

26.4K

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K